Apparent mineralocorticoid excess syndromes

Biglieri E.G., Kater C.E. Steroid characteristics of mineralocorticoid adrenocortical hypertension. Clin. Chem. 37: 1843, 1991.PubMedGoogle Scholar

Mantero F., Armanini D., Boscaro M., Carpene G., Fallo F., Opocher G., Rocco S., Scaroni C., Sonino N. Steroids and hypertension. J. Steroid. Biochem. Mol. Biol. 40: 35, 1991.PubMedGoogle Scholar

Fraser R., Davies D.L., Connell J.M.C. Hormones and hypertension. Clin. Endocrinol. 31: 701, 1989.Google Scholar

Melby J.C. Clinical Review 1; Endocrine Hypertension. J. Clin. Endocrinol. Metab. 69: 697, 1989.PubMedGoogle Scholar

Arriza J.L., Weinberger C., Cerelli G., Glaser T.M., Handelin B.L., Housman D.E., Evans R.M. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237: 268, 1987.PubMedGoogle Scholar

Stewart P.M., Wallace A.M., Atherden S.M., Shearing C.H., Edwards C.R.W. Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11ß-hydroxysteroid dehydrogenase activity in man. Clin. Sci. 78: 49, 1990.PubMedGoogle Scholar

Ulick S., Levine L.S., Gunczler P., Zanconato G., Ramirez L.C., Rauh W., Rösier A., Bradlow H.L., New M.L. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J. Clin. Endocrinol. Metab. 49: 757, 1979.PubMedGoogle Scholar

Whitworth J.A., Stewart P.M., Burt D., Atherden S.M., Edwards C.R.W. The kidney is the major site of cortisone production in man. Clin. Endocrinol. 31: 355, 1989.Google Scholar

Orth D.N., Kovacs W.J., Debold C.R. The adrenal cortex. In: Wilson J.D., Foster D.W. (Eds.), Williams Text Book of Endocrinology, (Ed. 8.) W.B. Saunders company, Philadelphia, 1992, p. 489.Google Scholar

Shackleton C.H.L., Stewart P.M. The hypertension of apparent mineralocorticoid excess (AME) syndrome. In: Biglieri E.G., Melby J.C. (Eds.), Endocrine hypertension. Raven Press, New York, 1990, p. 155.Google Scholar

Amelung D., Hübener H.J., Roka L., Meyerheim G. Conversion of cortisone to compound F. J. Clin. Endocrinol. Metab. 13: 1125, 1953.PubMedGoogle Scholar

Monder C., White P.C. 11ß-hydroxysteroid dehydrogenase. Vitam. Horm. 47: 187, 1993.PubMedGoogle Scholar

Stewart P.M. 11ß-hydroxysteroid dehydrogenase. In: Sheppard M.C., Stewart P.M. (Eds.), Baillière’s Clinical Endocrinology and Metabolism. Baillière Tindall, London, 1994, vol. 8, No. 2, p. 357.Google Scholar

Lakshmi V., Monder C. Purification and characterization of the corticosteroid 11ß-dehydrogenase component of the rat liver 11ß-hydroxysteroid dehydrogenase complex. Endocrinology 123: 2390, 1988.PubMedGoogle Scholar

Agarwal A.K., Tusie-Luna M.T., Monder C., White P.C. Expression of 11ß-hydroxysteroid dehydrogenase using recombinant vaccinia virus. Mol. Endocrinol. 4: 1827, 1990.PubMedGoogle Scholar

Monder C., Lakshmi V. Corticosteroid 11ß-dehydrogenate of rat tissues: immunological studies. Endocrinology. 126: 2435, 1990.PubMedGoogle Scholar

Agarwal A.K., Monder C., Eckstein B., White P.C. Cloning and expression of rat cDNA encoding corticosteroid 11ß-dehydrogenase. J. Biol. Chem. 264: 18939, 1989.PubMedGoogle Scholar

Krozowski Z., Stuchbery S., White P., Monder C., Funder J.W. Characterization of 11ß-hydroxysteroid dehydrogenase gene expression: indication of multiple unique forms of messenger ribonucleic acid in the rat kidney. Endocrinology. 127: 3009, 1990.PubMedGoogle Scholar

Whorwood C.B., Franklyn J.A., Sheppard M.C., Stewart P.M. Tissue localization of 11ß-hydroxysteroid dehydrogenase and its relationship to the glucocorticoid receptor. J. Steroid. Biochem. Mol. Biol. 41: 21, 1992.PubMedGoogle Scholar

Tannin G.M., Agarwal A.K. Monder C., New M.I., White P.C. The human gene for 11ß-hydroxysteroid dehydrogenase. J. Biol. Chem. 266: 16653, 1991.PubMedGoogle Scholar

Stewart P.M., Murry B.A., Mason J.I. Human kidney 11ß-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform. J. Clin. Endocrinol. Metab. 79: 480, 1994.PubMedGoogle Scholar

Whorwood C.B., Mason J.I., Ricketts M.L., Howie A.J., Stewart P.M. Detection of human 11ß-hydroxysteroid dehydrogenase isoforms using reverse-transcriptase-poly-merase chain reaction and localization of the type 2 isoform to renal collecting ducts. Mol. Cell. Endocrinol. 110: R7, 1995.PubMedGoogle Scholar

Edwards C.R.W., Stewart P.M., Burt D., Brett L., McIntyre M.A., Sutanto W.S., de Kloet E.R., Monder C. Localisation of 11ß-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 11: 986, 1988.Google Scholar

Rundle S.E., Funder J.W., Lakshmi V., Monder C. The intrarenal localization of mineralocorticoid receptors and 11ß-dehydrogenase: immunocyto-chemical studies. Endocrinology. 125: 1700, 1989.PubMedGoogle Scholar

Stewart P.M., Whorwood C.B., Barber P., Gregory J., Monder C., Franklyn J.A., Sheppard M.C. Localization of renal 11ß-dehydrogenase by in situ hybridization: autocrine not paracrine protector of the mineralocorticoid receptor. Endocrinology. 128: 2129, 1991.PubMedGoogle Scholar

Whorwood C.B., Barber P.C., Gregory J., Sheppard M.C., Stewart P.M. 11ß-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in the rat colon. Am. J. Physiol. 264: E951, 1993.PubMedGoogle Scholar

Krozowski Z., Wendell K., Ahima R., Harlan R. Type I corticosteroid receptor-like immunoreactivity in the rat salivary glands and distal colon: modulation by corticosteroids. Mol. Cell. Endocrinol. 85: 31, 1992.Google Scholar

Mercer W.R., Krozowski Z.S. Localization of an 11ß hydroxysteroid dehydrogenase activity to the distal nephron. Evidence for the existence of two species of dehydrogenase in the rat kidney. Endocrinology. 130: 540, 1992.Google Scholar

Walker B.R., Campbell J.C., Williams B.C., Edwards C.R.W. Tissue-specific distribution of the NAD+-dependent isoform of 11ß-hydroxysteroid dehydrogenase. Endocrinology. 131: 970, 1992.PubMedGoogle Scholar

Rusvai E., Náray-Fejes-Tóth A. A new isoform of 11ß-hydroxysteroid dehydrogenase in aldosterone target cells. J. Biol. Chem. 268: 10717, 1993.PubMedGoogle Scholar

Whorwood C.B., Ricketts M.L., Stewart P.M. Epithelial cell localization of type 2 11ß-hydroxysteroid dehydrogenase in rat and human colon. Endocrinology. 135: 2533, 1994.PubMedGoogle Scholar

Brown R.W., Chapman K.E., Edwards C.R.W., Seckl J.R. Human placental 11ß-hydroxysteroid dehydrogenase: evidence for partial purification of a distinct NAD-dependent isoform. Endocrinology. 132: 2614, 1993.PubMedGoogle Scholar

Stewart P.M., Murry B.A., Mason I. Type 2 11ß-hydroxysteroid dehydrogenase in human fetal tissues. J. Clin. Endocrinol. Metab. 78: 1529, 1994.PubMedGoogle Scholar

Albiston A.L., Obeyesekere V.R., Smith R.E., Krozowski Z.S. Cloning and tissue distribution of the human 11ß-hydroxysteroid dehydrogenase type 2 enzyme. Mol. Cell. Endocrinol. 105: R11, 1994.PubMedGoogle Scholar

Agarwal A.K., Mune T., Monder C., White P.C. NAD(+)-dependent isoform of 11beta-hydroxysteroid dehydrogenase. Cloning and characterization of cDNA from sheep kidney. J. Biol. Chem. 269: 25959, 1994.Google Scholar

Werder E., Zachman M., Vollmin J.A., Veyrat R., Prader A. Unusual steroid excretion in a child with low-renin hypertension. Res. Steroids 6: 385, 1974.Google Scholar

Sann L., Revol A., Zachmann M., Legrand J.C., Bethenod M. Unusual low plasma renin hypertension in a child. J. Clin. Endocrinol. Metab. 43: 265, 1975.Google Scholar

New M.I., Levine L.S., Biglieri E.G., Pareira J., Ulick S. Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension. J. Clin. Endocrinol. Metab. 44: 924, 1977.PubMedGoogle Scholar

Liddle G.W., Bledsoe T., Coppage W.S. A familial renal disorder simulating primary aldos-teronism but with negligible aldosterone secretion. Trans. Assoc. Am. Physicians. 76: 199, 1963.Google Scholar

Hyman P.E., Sha’afi R.I., Tan S.Y., Hintz R. Liddle’s syndrome. J. Pediatr. 95: 77, 1979.PubMedGoogle Scholar

Milora R., Vagnucci A., Goodman A.D. A syndrome resembling primary aldosteronism but without mineralocorticoid excess (MCE). Clin. Res. 15: 482, 1967. (abstract)Google Scholar

Helbock H.J., Reynolds J.W. Pseudoaldosteronism (Liddle’s syndrome): evidence for increased cell membrane permeability to Na+. Pediatr. Res. 4: 455, 1970. (abstract)Google Scholar

Shackleton C.H.L., Honour J.W., Dillon M.J., Chantier C., Jones R.W. Hypertension in a four-year-old child; gas chromatographic and mass spectrometric evidence for deficient hepatic metabolism of steroids. J. Clin. Endocrinol. Metab. 50: 786, 1980.PubMedGoogle Scholar

Ulick S., Ramirez L.C., New M.I. An abnormality in steroid reductive metabolism in a hypertensive syndrome. J. Clin. Endocrinol. Metab. 44: 799, 1977.PubMedGoogle Scholar

Marver D., Edelman I.S. Dihydrocortisol: a potential mineralocorticoid. J. Steroid. Biochem. 9: 1, 1978.PubMedGoogle Scholar

Oberfield S.E., Levine L.S., Carey R.M., Greig F., Ulick S., New M.I. Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 56: 332, 1983.PubMedGoogle Scholar

Fiselier T.J.W., Otten B.J., Monnens L.A.H., Honour J.W., van Munster P.J.J. Low-renin, low-aldosterone hypertension and abnormal cortisol metabolism in a 19-month old child. Horm. Res. 16: 107, 1982.PubMedGoogle Scholar

Honour J.W., Dillon M.J., Levin M., Shah V. Fatal, low renin hypertension associated with a disturbance of cortisol metabolism. Arch. Dis. Child. 58: 1018, 1983.PubMedCentralPubMedGoogle Scholar

Harinck H.I.J., van Brummelen P., van Seters A.P., Moolenaar A.J. Apparent mineralocorticoid excess and deficient 11ß-oxidation of cortisol in a young female. Clin. Endocrinol. 21: 505, 1984.Google Scholar

Shackleton C.H.L., Rodriguez J., Arteaga E., Lopez J.M., Winter J.S.D. Congenital 11ß-hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: corticosteroid metabolite profiles of four patients and their families. Clin. Endocrinol. 22: 701, 1985.Google Scholar

Monder C., Shackleton C.H.L., Bradlow H.L., New M.I., Stoner E., Iohan F., Lakshmi V. The syndrome of apparent mineralocorticoid excess: its association with 11ß-dehydrogenase and 5ß-reductase deficiency and some consequences for corticosteroid metabolism. J. Clin. Endocrinol. Metab. 63: 550, 1986.PubMedGoogle Scholar

Dimartino-Nardi J., Stoner E., Martin K., Balfe J.M., Jose P.A., New M.I. New findings in apparent mineralocorticoid excess. Clin. Endocrinol. 27: 49, 1987.Google Scholar

Nikkilä H., Tannin G.M., New M.I., Taylor N.F., Kalaitzoglou G., Monder C., White P.C. Defect in the HSD11 gene encoding 11ß-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency. J. Clin. Endocrinol. Metab. 77: 687, 1993.PubMedGoogle Scholar

Batista M.C., Mendonça B.B., Kater C.E., Arnhold I.J.P., Rocha A., Nicolau W., Bloise W. Spironolactone-reversible rickets associated with 11ß-hydroxysteroid dehydrogenase deficiency syndrome. J. Pediatr. 109: 989, 1986.PubMedGoogle Scholar

Milford D.V., Shackleton C.H.L., Stewart P.M. Mineralocorticoid hypertension and congenital deficiency of 11ß-hydroxysteroid dehydrogenase in a family with the syndrome of ‘apparent’ mineralocorticoid excess. Clin. Endocrinol. 42: In press, 1995.Google Scholar

Edwards C.R.W., Stewart P.M., Nairn I.M., Grieve J., Shackleton C.H.L. Cushing’s disease of the kidney. J. Endocrinol. 104 (S): 53, 1985. (abstract).Google Scholar

Stewart P.M., Corrie J.E.T., Shackleton C.H.L., Edwards C.R.W. Syndrome of apparent mineralocorticoid excess a defect in the cortisol-cortisone shuttle. J. Clin. Invest. 82: 340, 1988.PubMedCentralPubMedGoogle Scholar

Ulick S., Tedde R., Mantero F. Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 70: 200, 1990.PubMedGoogle Scholar

Ulick S., Tedde R., Wang J.Z. Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 74: 593, 1992.PubMedGoogle Scholar

Tedde R., Pala A., Melis A., Ulick S. Evidence for cortisol as the mineralocorticoid in the syndrome of apparent mineralocorticoid excess. J. Endocrinol. Invest. 15: 471, 1992.PubMedGoogle Scholar

Mantero F., Tedde R., Opocher G., Dessi Fulgheri P., Amaldi G., Ulick S. Apparent mineralocorticoid excess type II. Steroids 59: 80, 1994.PubMedGoogle Scholar

Speiser P.W., Riddick L.M., Martin K., New M.I. Investigation of the mechanism of hypertension in apparent mineralocorticoid excess. Metabolism 42: 843, 1993.PubMedGoogle Scholar

New M.I. The prismatic case of apparent mineralocorticoid excess J. Clin. Endocrinol. Metab. 79: 1, 1994.Google Scholar

Winter J.S.D., McKenzie J.K. A syndrome of low-renin hypertension in children. In: New M.I., Levine L.S. (Eds.), Juvenile hypertension. Raven Press, New York, 1977, p. 123.Google Scholar

Savage M.W., Barton R.N., Dornan T.L., Horan M.A., Robins A.J., Taylor N.F. Increased metabolic clearance of cortisol in corticosteroid 11-reductase deficiency. J. Endocrinol. 129 S): 219, 1991 (abstract).Google Scholar

Taylor N.F., Bartlett W.A., Dawson D.J., Enoch B.A. Cortisone reductase deficiency; evidence for a new inborn error in metabolism of adrenal steroids. J. Endocrinol. 102 (S): 90, 1984 (abstract).Google Scholar

Phillipou G., Higgins B.A. A new defect in the peripheral conversion of cortisone to cortisol. J. Steroid. Biochem. 22: 435, 1985.PubMedGoogle Scholar

Rodin A., Thakkar H., Taylor N., Clayton R. Hyperandrogenism in polycystic ovary syndrome — Evidence of dysregulation of 11ß-hydroxysteroid dehydrogenase. N. Engl. J. Med. 330: 460, 1994.PubMedGoogle Scholar

Davis E.A., Morris D.J. Medicinal uses of licorice through the millennia: the good and plenty of it. Mol. Cell. Endocrinol. 78: 1, 1991.PubMedGoogle Scholar

Reevers F. Behandling van uleus ventriculi in uleus duodeni met succus liquriate. Ned. Tijdschr. Geneesk. 92: 2968, 1946.Google Scholar

Card W.I., Mitchell W., Strong J.A., Taylor N.R.W., Tompsett S.L., Wilson J.M.G. Effects of liquorice and its derivatives on salt and water metabolism. Lancet i: 663, 1953.Google Scholar

Conn J.W., Rovner D.R., Cohen E.L. Licorice-induced pseudoaldosteronism. JAMA 205: 492, 1968.PubMedGoogle Scholar

Epstein M.T., Espiner E.A., Donald R.A., Hughes H. Effect of eating liquorice on the renin-angiotensin aldosterone axis in normal subjects. Br. Med. J. 1: 488, 1977.PubMedCentralPubMedGoogle Scholar

Epstein M.T., Espiner E.A., Donald R.A., Hughes H. Liquorice toxicity and the renin-angiotensin-aldosterone axis in man. Br. Med. J. 1: 209, 1977.PubMedCentralPubMedGoogle Scholar

Blachley J.D., Knochel J.P. Tobacco chewer’s hypokalemia: Licorice revisited. N. Engl. J. Med. 302: 784, 1980.PubMedGoogle Scholar

Salassa R.M., Mattox V.R., Rosevear J.W. Inhibition of the “Mineralocorticoid” activity of licorice by spironolactone. J. Clin. Endocrinol. Metab. 22: 1156, 1962.PubMedGoogle Scholar

Turpie A.G.G., Thomson T.J. Carbenoxolone sodium in the treatment of gastric ulcer with special reference to side-effects. Gut 5: 591, 1965.Google Scholar

Ulmann A., Menard J., Corvol P. Binding of glycyrrhetinic acid to kidney mineralocorticoid and glucocorticoid receptors. Endocrinology 97: 46, 1975.PubMedGoogle Scholar

Armanini D., Karbowiak I., Krozowski Z., Funder J.W., Adam W.R. The mechanism of mineralocorticoid action of carbenoxolone. Endocrinology 111: 1683, 1982.PubMedGoogle Scholar

Armanini D., Karbowiak I., Funder J.W. Affinity of liquorice derivatives for mineralocorticoid and glucocorticoid receptors. Clin. Endocrinol. 19: 609, 1983.Google Scholar

Louis L.H., Conn J.W. Preparation of glycyrrhizinic acid, the electrolyte-active principle of licorice: its effects upon metabolism and upon pituitary-adrenal function in man. J. Lab. Clin. Med. 47: 20, 1956.PubMedGoogle Scholar

Elmadjian F., Hope J.M., Pincus G. The action of mono-ammonium glycyrrhizinate on adrenalectomized subjects and its synergism with hydrocortisone. J. Clin. Endocrinol. Metab. 16: 338, 1956.PubMedGoogle Scholar

Borst J.G.G., Ten Holt S.P., De Vries L.A., Molhuysen L.A. Synergistic action of liquorice and cortisone in Addison’s and Simmonds’s disease. Lancet i: 657, 1953.Google Scholar

Girerd R.J., Rassaert C.L., DiPasquale G., Kroc R.L. Endocrine involvement in licorice hypertension. Am. J. Physiol. 198: 718, 1960.PubMedGoogle Scholar

Groen J., Pelser H., Willebrands A.F., Kamminga C.E. Extract of licorice for the treatment of Addison’s disease. N. Engl. J. Med. 244: 471, 1951.PubMedGoogle Scholar

Groen J., Pelser H., Frenkel M., Kamminga C.E., Willebrands A.F. Effect of glycyrrhizinic acid on the electrolyte metabolism in Addison’s disease. J. Clin. Invest. 31: 87, 1952.PubMedCentralPubMedGoogle Scholar

Epstein M.T., Espiner E.A., Donald R.A., Hughes H., Cowles R.J., Lun S. Licorice raises urinary cortisol in man. J. Clin. Endocrinol. Metab. 47: 397, 1978.PubMedGoogle Scholar

Monder C., Stewart P.M., Lakshmi V., Valentino R., Burt D., Edwards C.R.W. Licorice inhibits corticosteroid 11ß-dehydrogenase of rat kidney and liver: in vivo and in vitro studies. Endocrinology 125: 1046, 1989.PubMedGoogle Scholar

Souness G.W., Morris D.J. The antinatriuretic and kaliuretic effects of the glucocorticoids corticosterone and cortisol following pretreatment with carbenoxolone sodium (a liquorice derivative) in the adrenalectomized rat. Endocrinology 124: 1588, 1989.PubMedGoogle Scholar

Stewart P.M., Wallace A.M., Valentino R., Burt D., Shackleton C.H.L., Edwards C.R.W. Mineralocorticoid activity of liquolice: 11-ß-hydroxysteroid dehydrogenase deficiency comes of age. Lancet ii: 821, 1987.Google Scholar

MacKenzie M.A., Hoefnagels W.H.L., Jansen R.W.M.M., Benraad T.J., Kloppenborg P.W.C. The influence of glycyrrhetinic acid on plasma cortisol and cortisone in healthy young volunteers. J. Clin. Endocrinol. Metab. 70: 1637, 1990.PubMedGoogle Scholar

Farese R.V., Biglieri E.G., Shackleton C.H.L., Irony I., Gomez-Fontes R. Licorice-induced hypermineralocorticoidism. N. Engl. J. Med. 325: 1223, 1991.PubMedGoogle Scholar

Kageyama Y., Suzuki H., Saruta T. Glycyrrhizin induces mineralocorticoid activity through alterations in cortisol metabolism in the human kidney. J. Endocrinol. 135: 147, 1992.PubMedGoogle Scholar

Souness G.W., Morris D. The “mineralocorticoid-like” actions conferred on corticosterone by carbenoxolone are inhibited by the mineralocorticoid receptor (type I) antagonist RU28318. Endocrinology 129: 2451, 1991.PubMedGoogle Scholar

Whorwood C.B., Sheppard M.C., Stewart P.M. Licorice inhibits 11ß-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action. Endocrinology 132: 2287, 1993.PubMedGoogle Scholar

Stewart P.M., Whorwood C.B. 11ß-hydroxysteroid dehydrogenase activity and corticosteroid hormone action. Steroids 59: 90, 1994.PubMedGoogle Scholar

Monder C. Corticosteroids, kidneys, sweet roots and dirty drugs. Mol. Cell. Endocrinol. 78: C95, 1991.PubMedGoogle Scholar

Sheppard K., Funder J.W. Mineralocorticoid specificity of renal type I receptors: in vivo binding studies. Am. J. Physiol. 252: E224, 1987.PubMedGoogle Scholar

Stephenson G., Krozowski Z., Funder J.W. Extravascular CBG-like sites in rat kidney and mineralocorticoid receptor specificity. Am. J. Physiol. 246: F227, 1984.PubMedGoogle Scholar

Funder J.W., Pearce P.T., Smith R., Smith A.I. Mineralocorticoid actin: target tissue specificity is enzyme, not receptor, mediated. Science 242: 583, 1988.PubMedGoogle Scholar

Walker B.R., Stewart P.M., Shackleton C.H.L., Padfield P.L., Edwards C.R.W. Deficient inactivation of cortisol by 11ß-hydroxysteroid dehydrogenase in essential hypertension. Clin. Endocrinol. 39: 221, 1993.Google Scholar

Walker B.R., Yau J.L., Brett L.P., Seckl J.R., Monder C., Williams B.C., Edwards C.R.W. 11ß-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids. Endocrinology 129: 3305, 1991.PubMedGoogle Scholar

Walker B.R., Connacher A.A., Webb D.J., Edwards C.R.W. Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man. Clin. Sci. 83: 171, 1992.PubMedGoogle Scholar

Edwards C.R.W., Benediktsson R., Lindsay R.S., Seckl J.R. Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension? Lancet 341: 355, 1993.PubMedGoogle Scholar

Benediktsson R., Lindsay R.S., Noble J., Seckl J.R., Edwards C.R.W. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 341: 339, 1993.PubMedGoogle Scholar

Morris D.J., Semafuko W.E.B., Latif S.A., Vogel B., Grimes C.A., Sheff M.F. Detection of glycyrrhetinic acid-like factors (GALFs) in human urine. Hypertension 20: 356, 1992.PubMedGoogle Scholar

Walker B.R., Agarwal I., Stewart P.M., Padfield P.L., Edwards C.R.W. Endogenous inhibitors of 11ß-hydroxysteroid dehydrogenase in hypertension. J. Clin. Endocrinol. Metab. 80: 529, 1995.PubMedGoogle Scholar